The continuing legacy of the United Kingdom prospective diabetes study

Medical Journal of Australia

Volumn 180, Issue 3, 2004, Pages 104-105

  Davis, Timothy M E ^a   Colagiuri, Stephen ^b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; GLUCOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN; SULFONYLUREA;

BLOOD PRESSURE MEASUREMENT; CLINICAL TRIAL; DEATH; DIABETES MELLITUS; DIABETIC RETINOPATHY; DIET RESTRICTION; DIET THERAPY; DRUG EFFECT; EDITORIAL; FATALITY; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; KIDNEY FAILURE; MONOTHERAPY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PROSPECTIVE STUDY; RISK; STATISTICAL SIGNIFICANCE; STROKE; UNITED KINGDOM; VASCULAR DISEASE;

EID: 0842287439     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2004.tb05828.x     Document Type: Editorial

References (4)

1. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
2. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703-713.
3. The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 2002; 287: 2563-2569.
4. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998; 352: 854-865.